Huron Consulting(US:HURN)2026-02-24 23:02Financial Data and Key Metrics Changes - Revenues before reimbursable expenses (RBR) grew 11% in Q4 2025, reaching $432.3 million, compared to $388.4 million in Q4 2024 [33] - Full year RBR for 2025 was $1.66 billion, up 11.9% from $1.49 billion in 2024, marking the fifth consecutive year of growth [34] - Adjusted diluted earnings per share grew 21% in 2025, reaching a record $7.83 per share [39] - Adjusted EBITDA margin improved to 15.7% in Q4 2025, compared to 14.6% in Q4 2024, and for the full year, it was 14.3%, up from 13.5% in 2024 [38] Business Line Data and Key Metrics Changes - Healthcare segment RBR grew 10.7% in 2025, reaching a record $837.5 million, driven by strong demand for various services [41] - Education segment RBR was flat in Q4 2025 but grew 5.5% for the full year to $500.2 million, supported by strong demand for strategy and digital offerings [44] - Commercial segment RBR increased 36.6% in Q4 2025, reaching $91.9 million, and grew 27.2% for the full year to $325.1 million [47] Market Data and Key Metrics Changes - The healthcare segment accounted for 51% of total company RBR in Q4 2025, while education and commercial segments accounted for 28% and 21%, respectively [39] - The commercial segment saw a 20%+ increase in bookings in the second half of 2025 compared to the same period in 2024, indicating strong market demand [16] Company Strategy and Development Direction - The company is focused on sustaining strong growth in healthcare and education, which are its largest industries, while also expanding into adjacent markets [5] - The acquisition of AXIOM Systems' consulting services division aims to enhance payer-focused digital offerings and improve operational performance for clients [10] - The company is committed to achieving 15%-17% adjusted EBITDA margins by 2029, leveraging AI and automation for productivity gains [24] Management's Comments on Operating Environment and Future Outlook - Management noted that health systems are under pressure from reimbursement challenges and increasing operating costs, which drives demand for integrated solutions [8] - The company expects low double-digit percentage RBR growth in healthcare and mid-single-digit growth in education for 2026, with strong backlog coverage [58] - The pipeline remains at near-record levels, reflecting confidence in achieving growth targets for 2026 [58] Other Important Information - The company repurchased approximately 1.2 million shares in 2025, representing 6.6% of outstanding shares, and has an additional $200 million authorized for share repurchases [53][54] - 67% of total company RBR in 2025 was derived from outcomes-based, fixed-fee, and recurring revenue models, an increase from 50% in 2022 [28][29] Q&A Session Summary Question: Can you elaborate on the strong performance in the commercial segment? - Management confirmed a strong quarter for the commercial team, particularly in distressed financial advisory, with no significant one-time items affecting results [64][65] Question: Regarding guidance, is there more flexibility due to strong backlog coverage? - Management indicated that while there is confidence from strong backlog and bookings, the guidance approach remains cautious as they need to execute throughout the year [66][68] Question: Can you quantify the impact of AI on current projects? - Management noted that a significant portion of projects now incorporate AI, with estimates suggesting that around 50% of projects have a high or moderate AI component, up from 25% last year [70][72]